Abstract
Background Most Bluetooth-based exposure notification apps use three binary classifications to recommend quarantine following SARS-CoV-2 exposure: a window of infectiousness in the transmitter, ≥15 minutes duration, and Bluetooth attenuation below a threshold. However, Bluetooth attenuation is not a reliable measure of distance, and infection risk is not a binary function of distance, nor duration, nor timing.
Methods We model uncertainty in the shape and orientation of an exhaled virus-containing plume and in inhalation parameters, and measure uncertainty in distance as a function of Bluetooth attenuation. We calculate expected dose by combining this with estimated infectiousness based on timing relative to symptom onset. We calibrate an exponential dose-response curve on the basis of the infection probabilities of household contacts. The conditional probability of current or future infectiousness, conditioned on how long post-exposure an exposed individual has been free of symptoms, decreases during quarantine, with shape determined by the distribution of incubation periods, proportion of asymptomatic cases, and distribution of asymptomatic shedding durations. It can be adjusted for negative test results using Bayes Theorem.
Findings We capture a 10-fold range of risk using 6 infectiousness values, 11-fold range using 3 Bluetooth attenuation bins, ~6-fold range from exposure duration given the 30 minute duration cap imposed by the Google/Apple v1.1, and ~11-fold between the beginning and end of 14 day quarantine. Imposing a consistent risk threshold for the probability of infection can recommend quarantine with weaker Bluetooth signal, even when not recommended for the entirety of the infectious period.
Interpretation The Covid-Watch app is currently programmed either to use a threshold on initial infection risk to determine 14-day quarantine onset, or on the conditional probability of current and future infectiousness conditions to determine both quarantine and duration. Either threshold can be set by public health authorities.
Funding University of Arizona
Research in Context Evidence before this study
Epidemiological models suggest a benefit from smartphone-based automatic notification of exposure to Covid-19 infected individuals. Google and Apple have rolled out a privacy-preserving API with which apps can offer such notifications based on the degree of Bluetooth attenuation of a signal issued by an infected individual, its duration, and its timing relative to symptom onset in and test date for that infected individual. Apps deployed so far have focused on approximating close contact definitions of 15 minutes and a given distance such as 1 meter or 2 meters. However, Bluetooth attenuation is not a reliable measure of distance, and infection risk is not a binary function of distance, nor duration, nor timing.
Added value of this study We integrate all sources of information (including our own new experiments on the relationship between distance and Bluetooth attenuation) to provide a measure of infection risk that is as accurate as possible given the data on exposure that is available to an app based on the Google/Apple system. We also provide a method to calculate the probability of current or future infectiousness, which is a function not only of initial infection risk, but also of the number of symptom-free days since exposure, and any negative test results.
Implications of all available evidence
Our risk scoring system can guide quarantine recommendations in exposure notification apps, targeting them to individuals who are the most likely to be infected. It can also recommend release from quarantine on the day that the probability of current or future infectiousness falls below a threshold, leading to different quarantine durations for different individuals.
Competing Interest Statement
JIP, ZS, MX, SH, TW, and JM are members of Covid Watch, a 501 (c)(3) non-profit developing open source code software for exposure notifications. The organization is also involved in providing commercial solutions around the technology.
Funding Statement
Funding was provided by the University of Arizona.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
A research protocol for Alpha testing was submitted for University of Arizona ethics review and deemed not human subjects research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We now report on the application of the method to data, and the resulting tuning of parameters. Many other small changes throughout.
Data Availability
The code is available at the github link provided in the text. The Supplementary Datafile is currently available to reviewers and on request, and will be freely available upon journal publication.
